|
(Health-NewsWire.Net, May 22, 2021 ) According to market research report the global Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392
Increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population are expected to boost the growth of this market in the coming years.
Emerging economies such as Brazil, India and China are expected to provide a wide range of opportunities for players in the industry.
Clinical laboratories dominated the Coagulation Analyzer Market in 2019
On the basis of end user, the Hemostasis Analyzer Market is segmented into clinical laboratories, hospitals, and other end users. In 2019, the clinical laboratories segment accounted for the largest share of the market.
Clinical laboratory analyzers dominated the Coagulation Analyzer Market in 2019
Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market. The large share of this segment can be attributed to factors such as the growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities.
Optical technology segment accounted for the largest share of the Coagulation Analyzer Market, by technology, in 2019
The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies. The most widely used technology in the Hemostasis Analyzer Market is the optical technology. This segment accounted for the largest share of the market in 2019.
North America is the largest regional market for coagulation analyzers
North America (comprising the US and Canada) accounted for the largest share of the global Coagulation Analyzer Market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the market in North America.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392
Recent Developments:
> In 2019, Nihon Kohden established a hematology analyzer reagent factory in Dubai.
> In 2018, Sysmex launched the Automated Blood Coagulation Analyzers CN-6000 and CN-3000
> In 2017, Roche Diagnostics launched the cobas t 711 coagulation analyzer
Siemens Healthineers (Germany), Thermo Fisher Scientific (US), Roche Diagnostics (Switzerland), Alere, Inc. (US), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), and Horiba Medical (Japan) are some of the key players operating in this Coagulation Analyzer Market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
